Cite

    Nishimura, R. et al. (2016). Sodium‐glucose cotransporter 2 inhibitor luseogliflozin improves glycaemic control, assessed by continuous glucose monitoring, even on a low‐carbohydrate diet. Diabetes, obesity & metabolism. 18 (7), pp. 702-706. [Online].